| Serial Number | 87290975 |
| Word Mark | IO? |
| Filing Date | Thursday, January 5, 2017 |
| Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
| Status Date | Monday, May 22, 2023 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form |
| Published for Opposition Date | Tuesday, February 25, 2020 |
| Goods and Services | (Based on 1(b)) Provision of education, namely, training in the fields of healthcare, pharmaceuticals, medical devices, medical research, surgery, medical science and medicine and patient care; Provision of education and training, namely, developing, arranging and conducting live and online educational conferences, seminars, classes, lectures, panel discussions, workshops and programs and providing courses of instruction in the fields of healthcare, pharmaceuticals, medical devices, medical research, surgery, medical science and medicine and patient care and distribution of course materials in connection therewith; Provision of education and training, namely, providing non-downloadable webinars in the fields of healthcare, pharmaceuticals, medical devices, medical research, surgery, medical science and medicine and patient care and distribution of course materials in connection therewith; Provision of education and training, namely, conducting online and telephonic instruction and courses in the fields of healthcare, pharmaceuticals, medical devices, medical research, surgery, medical science and medicine and patient care; Provision of education and training, namely, development of multi-media educational content for use with mobile devices and computers in relation to healthcare, pharmaceuticals, medical devices, medical research, surgery, medical science and medicine and patient care; Arranging, and conducting educational conferences and programs and providing courses of instruction in the fields of healthcare, pharmaceuticals, medical devices, medical research, surgery, medical science and medicine and patient care; Provision and publication of educational material and content, namely, publication of teaching guides, instructional materials, brochures and providing on-line non-downloadable publications in the nature of teaching guides, instructional materials, and brochures in the fields of healthcare, pharmaceuticals, medical devices, medical research, surgery, medical science and medicine and patient care; Conducting educational seminars in the fields healthcare, pharmaceuticals, medical devices, medical research, surgery, medical science and medicine and patient care and distribution of course materials therewith; Information and advice relating to education and training provided online from a computer database or the internet, all relating to healthcare, pharmaceuticals, medical devices, medical research, surgery, medical science and medicine and patient care; Provision of educational information, namely, providing on-line instruction in the fields healthcare, pharmaceuticals, medical devices, medical research, surgery, medical science and medicine and patient care provided on-line from a computer database |
| Description of Mark | The mark consists of the letters "IO" with the "2" as a superscript. |
| Goods and Services | (Based on 44(e)) Pharmaceutical, medicinal and veterinary preparations and substances, namely, vaccines, antitoxic sera, pharmaceutical preparations for the treatment of cancer, pharmaceutical preparations and substances for the treatment of thrombosis, embolisms, inflammation, and autoimmune disease, pharmaceutical preparations for the treatment of envenomation by snakes, veterinary preparations for the treatment of envenomation by snakes, liquid medical sealants, and liquid adhesives for use in surgical and clinical procedure; sanitary preparations for medical purposes; vaccines; pharmaceutical and medicinal preparations and substances, namely, sera containing polyclonal antibodies and fragments thereof and polyclonal antibodies and fragments derived therefrom all for use in treating snake envenomation, overdose of toxic substances, and sepsis; medical diagnostic reagents and substances, all for in vivo use; antibodies and therapeutic antibodies for use as anti-lymphocytic agents for medical use; pharmaceutical preparations in the form of foams or for use in producing foams, for sclerotherapy, phlebology, angiology or proctology, for treatment of oesophageal varices, hydroceles, in sterilisation treatment or for treatment of varicose veins, or arterio-venous malformations; chemical reagents for medical or veterinary purposes; chemical reagents for medical therapeutic and diagnostic purposes; chemical reagents for medical and veterinary purposes for the treatment of envenomation by snakes; chemical reagents for therapeutic and diagnostic purposes for the treatment of envenomation by snakes; chemico-pharmaceutical preparations for the treatment of envenomation by snakes; chemico-pharmaceutical preparations for use in the treatment of pre-eclampsia; chemical preparations for medical or pharmaceutical purposes for use in the prevention and treatment of cancer, circulatory system issues and conditions, pulmonary embolisms, thrombus, deep vein thrombosis, peripheral arterial occlusions, blood clots, vascular issues and conditions, and intracranial hemorrhages, cerebral hemorrages, and hematoma; pharmaceutical preparations for the treatment of cancer; pharmaceutical and veterinary preparations for the reduction or elimination of circulating cytokines; pharmaceutical and veterinary preparations for the treatment of hypertension; pharmaceutical preparations for the treatment of migraine; pharmaceutical preparations for the treatment of multiple neurodegeneration and multiple sclerosis; pharmaceutical preparations for the treatment of Alzheimer's disease; pharmaceutical preparations for the treatment of immune disorders, namely, type 1 diabetes, psoriasis, coeliac disease and rheumatoid arthritis; pharmaceutical preparations for the treatment of sepsis; pharmaceutical and veterinary preparations for the treatment of digoxin, digitalis or other cardio-active glycoside toxicity; pharmaceutical and veterinary preparations for treatment of envenomation by snakes; pharmaceutical preparations for the treatment of methotrexate toxicity; pharmaceutical preparations for the treatment of cancer including prostate, oesophageal and brain cancer and leukaemias; preparations and substances for facilitating the delivery of pharmaceutical and medicinal preparations and substances, namely, drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; pharmaceutical preparations and substances for use in the circulatory system; pharmaceutical preparations and substances for embolization; pharmaceutical preparations and substances for embolization of tumours and arteriovenous malformations (AVMs); pharmaceutical preparations and substances for use in the circulatory system for the treatment of tumours and AVMs; adjuvants for medicinal purposes, vaccine adjuvants and vaccine preparations containing adjuvant; chemical reagents for medical or veterinary purposes for the treatment of envenomation by snakes; chemical reagents for therapeutic and diagnostic purposes for the treatment of envenomation by snakes; chemical preparations for medical or pharmaceutical purposes for the treatment of envenomation by snakes; medicines for the treatment of envenomation by snakes; chemical reagents for medical or veterinary therapeutic and medical diagnostic purposes; chemico-pharmaceutical preparations for use in the treatment of digoxin, digitalis or other cardio-active glycoside toxicity; chemical preparations for medical or pharmaceutical purposes and medicines for use in the treatment of digoxin, digitalis or other cardio-active glycoside toxicity; transarterial chemoembolization pharmaceutical preparations, vaccines and antitoxic sera; pharmaceutical preparations and substances for facilitating the delivery of pharmaceutical and medicinal preparations and substances; irradiated or radioactive microspheres used for in vivo therapeutic medical purposes; radiotherapy substances for medical purposes, namely, radioactive pharmaceutical preparations for medical purposes for the treatment of cancer; radiotherapy substances for medical purposes, namely, radioactive pharmaceutical preparations for medical purposes for the treatment of cancer; radiopharmaceuticals, namely, radiopharmaceuticals for the treatment of cancer and radiopharmaceutical preparations for use in nuclear medicine; therapeutic agents for delivery of radioactive material to target sites within the body; Pharmaceutical preparations being beads, including microscopic radioactive beads, for treatment of cancerous tumours; beads, including microscopic glass beads, impregnated with radioactive material for treatment of cancerous tumours; beads, including microscopic glass beads, impregnated with radioactive pharmaceutical preparations and consisting of radioactive material for treatment of cancerous tumors; radioactive glass beads impregnated with pharmaceutical preparations for the treatment of cancer; irradiated and radioactive microspheres used for in vivo therapeutic medical purposes, namely, beads in the nature of microscopic glass beads impregnated with radioactive pharmaceutical preparations for treatment of cancerous tumors; pharmaceutical preparations for use with ultrasound waves to enhance drug delivery and/or medically activate drugs; pharmaceutical preparations in the form of foams for use in sclerotherapy treatment of veins; pharmaceutical preparations in the form of foams for use in producing foams for use in sclerotherapy treatment of veins; pharmaceutical preparations in the form of foams or for use in producing foams for sclerotherapy, phlebology, angiology and proctology, for treatment of oesophageal varices, hydroceles, in sterilisation treatment or for treatment of varicose veins, or arterio-venous malformations; pharmaceutical preparations containing methotrexate antidotes; pharmaceutical preparations containing 5-fluorouracil antidotes; pharmaceutical preparations for use in chemotherapy and autoimmune diseases; pharmaceutical preparations used for regulating toxicity levels of therapeutic agents; pharmaceutical preparations used for depleting concentrations of therapeutic agents |
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| Goods and Services | (Based on 1(b)) Provision of medical and surgical information; Provision of medical and surgical information on-line from a computer database or from the Internet or by telecommunication means; Providing medical information; Providing a website featuring information regarding medicine, medical treatment, medical patient care, therapeutic properties of prescription drugs, pharmaceutical advice, dispensing of pharmaceuticals, medical treatment and medical patient care aftercare; Providing a website featuring medical information regarding medicine, medical treatment, medical patient care, therapeutic properties of prescription drugs, pharmaceutical advice, dispensing of pharmaceuticals, medical treatment and medical patient care aftercare; Providing healthcare information; Providing information about medical devices for use in medical procedures and surgery; Providing information about healthcare; Providing information in the field of healthcare, therapeutic properties of pharmaceuticals, medical devices for use in medical procedures and surgery, surgery, and medicine and medical patient care; Providing information in the field of healthcare, therapeutic properties of pharmaceuticals, medical devices for use in medical procedures and surgery, surgery, and medicine and medical patient care by means of computer, electronic and online databases |
| Goods and Services | (Based on 44(e)) Surgical, medical, dental and veterinary apparatus and instruments, namely, cryoablation needles, medical syringes, electrically powered tissue ablation devices, artificial limbs, orthopaedic articles, namely, implants made of artificial materials, haemofiltration devices for medical use, apparatus for generating and transmitting ultrasound for medical and diagnostic use, surgical and medical apparatus and instruments for use in minimally invasive cryoablation procedures, electronic apparatus and instruments for use in relation to ultrasound imaging and scanning for medical and diagnostic use, and medical and diagnostic imaging units; Surgical and medical apparatus, instruments and devices for the treatment of chronic lung disease including emphysema; medical syringes, medical cannula needles, medical tubing; surgical and medical apparatus for producing and administering pharmaceutical foams; surgical and medical apparatus and instruments for producing and administering sclerosing foams; surgical and medical apparatus and instruments for producing foams for use in sclerotherapy, phlebology, angiology or proctology, sterilisation treatment or for treatment of varicose veins, arterio-venous malformations, oesophageal varices or hydroceles; surgical and medical devices for assessing the physical characteristics of such foams, namely, devices for intravenous administration of foam, medical diagnostic apparatus for analyzing the efficacy of sclerotherapy foams for medical purposes, medical diagnostic devices for grading the severity of venous conditions, snake envenomation and toxic drugs overdose, and devices for monitoring the position and effect of foam in the human body; medical diagnostic devices for diagnosing all the above medical conditions, namely, varicose veins, arterio-venous malformations, oesophageal varices, spider veins, hydroceles, cancer, tumors, and circulatory system conditions and pulmonary and thoracic conditions; drug delivery embolisation apparatus, instruments and systems; apparatus and instruments for use in the circulatory system; apparatus and instruments for embolisation; surgical and medical apparatus and instruments, namely, catheters, injection syringes and sealed vial devices for dispensing microspheres during embolisation procedures in blood vessels and in the circulatory system; embolisation apparatus, instruments and systems comprising surgical and medical instruments for embolisation; drug delivery embolisation systems; drug delivery apparatus and instruments comprised of injection syringes, and sealed vials; injection syringes for use with catheters; apparatus and instruments for use in the circulatory system, namely, catheters, injection syringes and sealed vials; medical apparatus and instruments for embolisation, namely, medical devices in the nature of particles, namely, embolic microspheres for embolization; surgical and medical apparatus and instruments for embolisation, namely, embolisation apparatus, instruments and systems comprising microspheres and injection syringes for use in blood vessels and the circulatory system to carry out embolisation; radiotherapy apparatus; surgical and medical apparatus and instruments for delivery of radiopharmaceuticals and radioactive material to target sites within the body; beads, namely, microscopic glass beads, impregnated with radioactive material or containing radioactive material and administered surgically for treatment of cancerous tumours; radioactive beads, namely, radioactive glass beads administered for treatment of cancerous tumours; surgical and medical apparatus and instruments for use in the circulatory system; medical devices which use ultrasound to enhance drug delivery and/or medically activate drugs; catheters for delivery of drugs or fluids sold together as a unit with controllers and power units for infusion catheters; ultrasonic drug delivery and drug activation apparatus sold together as a unit with controllers and power units therefor; needles for medical use, namely, cannula needles; medical tubing for sclerotherapy; medical tubing for the treatment of varicose veins, venous malformations, arterio-venous malformations, oesophageal varices and hydroceles; surgical and medical apparatus for producing and administering foams for the treatment of varicose veins, venous malformations, arterio-venous malformations, oesophageal varices and hydroceles; surgical and medical apparatus for producing and administering sclerosing foams for the treatment of varicose veins, venous malformations, arterio-venous malformations, oesophageal varices and hydroceles; syringes for producing and administering foams for use in sclerotherapy, phlebology, angiology or proctology; surgical and medical apparatus for administering and producing foams for use in sterilisation treatment; surgical and medical apparatus for use in treatment of varicose veins, arterio-venous malformations, oesophageal varices or hycroceles; syringes for use in treatment of varicose veins, arterio-venous malformations, oesophageal varices or hydroceles; medical devices for intravenous administration of sclerosing foam for the treatment of varicose veins, venous malformations, arterio-venous malformations, oesophageal varices and hydroceles; medical devices for monitoring the position and effect of foam in the human body; medical diagnostic apparatus for diagnosing all the above medical conditions, namely, varicose veins, arterio-venous malformations, oesophageal varices, spider veins, hydroceles, cancer, tumors, and circulatory system conditions and pulmonary and thoracic conditions; compression bandages; surgical instruments and apparatus and medical diagnostic apparatus for use in interventional pulmonology; medical devices for use in pulmonary and thoracic surgery and procedures; medical devices for use in pulmonary and thoracic surgery, namely, lung volume reduction devices; artificial surgical implants for use in interventional pulmonology; surgical implants comprising artificial surgical implants for restoring, maintaining and improving patient breathing, and artificial surgical implants for restoring, maintaining and improving lung function; medical devices for performing cryotherapy, namely, cryosurgical probes and cryoablation needles used for the minimally invasive cryoablation of cancerous and benign tissues; medical apparatus consisting of treatment probes and high pressure valves used for heat or freeze treatment incorporating computer software; surgical instruments and apparatus and medical diagnostic apparatus for use in cryoablation, and the treatment of prostate cancer, kidney or renal tumours, and benign prostatic hyperplasia (BPH ); medical devices used to deliver heat to target sites using electrical current through needles; medical devices to deliver cryogen gas for freezing and either cryogen gas or electrical current for heating for treatment of cancer and tumors; medical devices for ablating human and animal tissue using microwave energy; medical devices for treating cancerous and benign tissue using microwave energy; replacement and structural parts and fittings for all of the aforesaid goods |
| Goods and Services | (Based on 1(b)) Providing on-line, non-downloadable educational software featuring instruction in the fields of healthcare, the use of pharmaceuticals and medical devices, medical research, surgery, medical science, medicine, medical diseases, disorders and related treatments; Information about medical research; Providing educational information in the field of medical research; Providing educational information in the field of medical research by means of computer, electronic and online databases; Information about pharmaceutical research; Providing educational information in the field of pharmaceutical research; Providing educational information in the field of pharmaceutical research by means of computer, electronic and online databases |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, January 13, 2017 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
| US Class Codes | 026, 039, 044 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, January 13, 2017 |
| Primary Code | 010 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 041 - Education; providing of training; entertainment; sporting and cultural activities. |
| US Class Codes | 100, 101, 107 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, January 13, 2017 |
| Primary Code | 041 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, October 3, 2019 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, October 3, 2019 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | BTG International Limited |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | London EC4M7RD GB |
| Party Name | BTG International Limited |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | London EC4M7RD GB |
| Event Date | Event Description |
| Monday, May 22, 2023 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| Monday, May 22, 2023 | ABANDONMENT - NO USE STATEMENT FILED |
| Thursday, March 16, 2023 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Thursday, March 16, 2023 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Thursday, March 16, 2023 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Thursday, March 16, 2023 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Thursday, March 16, 2023 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Friday, August 19, 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, August 18, 2022 | SOU EXTENSION 5 GRANTED |
| Wednesday, August 17, 2022 | SOU EXTENSION 5 FILED |
| Wednesday, August 17, 2022 | SOU TEAS EXTENSION RECEIVED |
| Friday, March 4, 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, March 3, 2022 | SOU EXTENSION 4 GRANTED |
| Thursday, February 24, 2022 | SOU EXTENSION 4 FILED |
| Thursday, February 24, 2022 | SOU TEAS EXTENSION RECEIVED |
| Thursday, October 7, 2021 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Wednesday, October 6, 2021 | SOU EXTENSION 3 GRANTED |
| Tuesday, October 5, 2021 | SOU EXTENSION 3 FILED |
| Tuesday, October 5, 2021 | SOU TEAS EXTENSION RECEIVED |
| Thursday, April 29, 2021 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Wednesday, April 28, 2021 | SOU EXTENSION 2 GRANTED |
| Monday, March 29, 2021 | SOU EXTENSION 2 FILED |
| Thursday, April 1, 2021 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Monday, March 29, 2021 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, March 23, 2021 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Monday, March 22, 2021 | SOU EXTENSION 1 GRANTED |
| Wednesday, October 21, 2020 | SOU EXTENSION 1 FILED |
| Monday, March 22, 2021 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Monday, January 11, 2021 | NOTICE OF REVIVAL - E-MAILED |
| Monday, January 11, 2021 | SOU EXTENSION RECEIVED WITH TEAS PETITION |
| Monday, January 11, 2021 | PETITION TO REVIVE-GRANTED |
| Monday, January 11, 2021 | TEAS PETITION TO REVIVE RECEIVED |
| Monday, November 23, 2020 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| Monday, November 23, 2020 | ABANDONMENT - NO USE STATEMENT FILED |
| Sunday, August 30, 2020 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Sunday, August 30, 2020 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Sunday, August 30, 2020 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS |
| Sunday, August 30, 2020 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Sunday, August 30, 2020 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Sunday, August 30, 2020 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Tuesday, April 21, 2020 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, February 25, 2020 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, February 25, 2020 | PUBLISHED FOR OPPOSITION |
| Wednesday, February 5, 2020 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Thursday, January 23, 2020 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Thursday, January 16, 2020 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, January 15, 2020 | EXAMINER'S AMENDMENT ENTERED |
| Wednesday, January 15, 2020 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Wednesday, January 15, 2020 | EXAMINERS AMENDMENT E-MAILED |
| Wednesday, January 15, 2020 | EXAMINERS AMENDMENT -WRITTEN |
| Tuesday, December 31, 2019 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, December 31, 2019 | NON-FINAL ACTION E-MAILED |
| Tuesday, December 31, 2019 | NON-FINAL ACTION WRITTEN |
| Tuesday, December 10, 2019 | PREVIOUS ALLOWANCE COUNT WITHDRAWN |
| Tuesday, November 12, 2019 | WITHDRAWN FROM PUB - OG REVIEW QUERY |
| Tuesday, October 29, 2019 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Thursday, October 3, 2019 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, October 3, 2019 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, September 27, 2019 | EXAMINER'S AMENDMENT ENTERED |
| Friday, September 27, 2019 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Friday, September 27, 2019 | EXAMINERS AMENDMENT E-MAILED |
| Friday, September 27, 2019 | EXAMINERS AMENDMENT -WRITTEN |
| Monday, August 26, 2019 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, August 26, 2019 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, August 23, 2019 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
| Friday, August 23, 2019 | EX PARTE APPEAL-INSTITUTED |
| Friday, August 23, 2019 | JURISDICTION RESTORED TO EXAMINING ATTORNEY |
| Friday, August 23, 2019 | EXPARTE APPEAL RECEIVED AT TTAB |
| Monday, February 25, 2019 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Monday, February 25, 2019 | FINAL REFUSAL E-MAILED |
| Monday, February 25, 2019 | FINAL REFUSAL WRITTEN |
| Monday, February 4, 2019 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, February 4, 2019 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, February 1, 2019 | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED |
| Tuesday, October 2, 2018 | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED |
| Tuesday, September 18, 2018 | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION |
| Thursday, March 8, 2018 | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED |
| Wednesday, March 7, 2018 | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION |
| Saturday, September 2, 2017 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Saturday, September 2, 2017 | LETTER OF SUSPENSION E-MAILED |
| Saturday, September 2, 2017 | SUSPENSION LETTER WRITTEN |
| Wednesday, August 23, 2017 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, August 22, 2017 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, August 22, 2017 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, March 7, 2017 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, March 7, 2017 | NON-FINAL ACTION E-MAILED |
| Tuesday, March 7, 2017 | NON-FINAL ACTION WRITTEN |
| Saturday, March 4, 2017 | ASSIGNED TO EXAMINER |
| Friday, February 10, 2017 | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED |
| Thursday, February 9, 2017 | ASSIGNED TO LIE |
| Friday, January 27, 2017 | TEAS VOLUNTARY AMENDMENT RECEIVED |
| Friday, January 13, 2017 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, January 9, 2017 | NEW APPLICATION ENTERED |